NSD3 and cancer: A number of genes are novel drug candidates for future drug development efforts, such as NSD3. Other genes may serve as potential diagnostic markers to predict drug response/resistance, such as GRB7. The TCGA efforts have advanced our understanding of cancer biology by identifying the primary genetic drivers of cancer and linking novel therapeutics to these genetic backgrounds.